ZIM Laboratories Limited (BOM:541400)
India · Delayed Price · Currency is INR 131.80
-5.70 (-4.15%)
At close: Nov 6, 2026
ZIM Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 4,136 | 3,744 | 3,790 | 3,674 | 3,985 | 3,334 |
Other Revenue | -2.25 | - | - | 0.93 | 0.82 | 0.82 |
| 4,133 | 3,744 | 3,790 | 3,675 | 3,986 | 3,335 | |
Revenue Growth | 13.05% | -1.22% | 3.13% | -7.80% | 19.52% | 8.51% |
Cost of Revenue | 1,947 | 1,770 | 1,758 | 1,815 | 2,072 | 1,670 |
Gross Profit | 2,187 | 1,974 | 2,032 | 1,860 | 1,914 | 1,665 |
Selling, General & Admin | 749.63 | 671.26 | 636.43 | 554.67 | 514.55 | 414.78 |
Other Operating Expenses | 1,150 | 992.64 | 928.78 | 877.91 | 871.97 | 839.1 |
Operating Expenses | 2,128 | 1,871 | 1,788 | 1,603 | 1,561 | 1,415 |
Operating Income | 58.82 | 102.99 | 244.7 | 256.66 | 352.59 | 250.31 |
Interest Expense | -131.94 | -120.76 | -102.47 | -58.82 | -49.7 | -71.69 |
Interest & Investment Income | 3.34 | 3.34 | 3.33 | 1.36 | 3.43 | 2.9 |
Currency Exchange Gain (Loss) | 76.79 | 76.79 | 41.44 | 38.06 | 55.49 | 38.54 |
Other Non Operating Income (Expenses) | -5.4 | -5.4 | -8.89 | -0.68 | -1.66 | -9.6 |
EBT Excluding Unusual Items | 1.61 | 56.96 | 178.11 | 236.58 | 360.15 | 210.46 |
Gain (Loss) on Sale of Assets | 25.52 | 25.52 | 3.35 | -0.16 | - | - |
Asset Writedown | -0.35 | -0.35 | -1.37 | - | -6.6 | -0.03 |
Pretax Income | 26.78 | 82.13 | 180.09 | 236.42 | 353.55 | 210.43 |
Income Tax Expense | 6.07 | 23.75 | 58.44 | 63.96 | 109.21 | 64.92 |
Earnings From Continuing Operations | 20.71 | 58.38 | 121.65 | 172.46 | 244.35 | 145.5 |
Minority Interest in Earnings | 0 | - | 0 | 0 | - | - |
Net Income | 20.72 | 58.38 | 121.65 | 172.46 | 244.35 | 145.5 |
Net Income to Common | 20.72 | 58.38 | 121.65 | 172.46 | 244.35 | 145.5 |
Net Income Growth | -68.55% | -52.01% | -29.46% | -29.42% | 67.93% | 98.84% |
Shares Outstanding (Basic) | 51 | 49 | 49 | 49 | 49 | 49 |
Shares Outstanding (Diluted) | 51 | 49 | 49 | 49 | 49 | 49 |
Shares Change | 5.43% | 0.52% | - | - | - | 0.09% |
EPS (Basic) | 0.40 | 1.19 | 2.50 | 3.54 | 5.01 | 2.99 |
EPS (Diluted) | 0.40 | 1.19 | 2.50 | 3.54 | 5.01 | 2.99 |
EPS Growth | -70.30% | -52.34% | -29.46% | -29.35% | 67.77% | 99.08% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -242.3 | 51.48 | 3.57 | -576.45 | 15 | 339.81 |
Free Cash Flow Per Share | -4.72 | 1.05 | 0.07 | -11.83 | 0.31 | 6.97 |
Gross Margin | 52.91% | 52.74% | 53.62% | 50.60% | 48.01% | 49.93% |
Operating Margin | 1.42% | 2.75% | 6.46% | 6.98% | 8.85% | 7.51% |
Profit Margin | 0.50% | 1.56% | 3.21% | 4.69% | 6.13% | 4.36% |
Free Cash Flow Margin | -5.86% | 1.38% | 0.09% | -15.68% | 0.38% | 10.19% |
EBITDA | 224.79 | 248.37 | 394.53 | 390.59 | 499 | 387.91 |
EBITDA Margin | 5.44% | 6.63% | 10.41% | 10.63% | 12.52% | 11.63% |
D&A For EBITDA | 165.97 | 145.38 | 149.83 | 133.94 | 146.41 | 137.6 |
EBIT | 58.82 | 102.99 | 244.7 | 256.66 | 352.59 | 250.31 |
EBIT Margin | 1.42% | 2.75% | 6.46% | 6.98% | 8.85% | 7.51% |
Effective Tax Rate | 22.66% | 28.92% | 32.45% | 27.05% | 30.89% | 30.85% |
Revenue as Reported | 4,247 | 3,858 | 3,848 | 3,726 | 4,049 | 3,378 |
Advertising Expenses | - | 28.29 | 25.39 | 19.11 | 19.14 | 9.03 |